Demand surge for 'game changer' COVID-19 drug hydroxychloroquine despite lack of clinical evidence

Though there have been no large-scale clinical trials of the drug's efficacy in treating coronavirus, chemists all over say they are facing a shortage of the medicine, not so long ago known mainly to those who had malaria or were prescribed it for arthritis pain. While the demand for hydrochloroqine has seen a rapid uptick, the safety and effectiveness of the drug in treating COVID-19 still remains a concern.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news